This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Cannot Therapeutics, Inc., Carmot Therapeutics, Inc.. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Steven Sethofer: Innovator in G-Protein Coupled Receptor Modulation
Introduction
Steven Sethofer is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of pharmacology, particularly in the modulation of G-protein coupled receptors. With a total of 2 patents, his work focuses on developing chemical entities that can effectively treat various diseases and disorders.
Latest Patents
Sethofer's latest patents include innovative disclosures related to modulators of glucagon-like peptide-1 receptor (GLP-1R) and gastric inhibitory polypeptide receptor (GIPR). These chemical entities are designed to modulate receptor activities, which can be beneficial for treating conditions where modulation of GLP-1R and GIPR is necessary. The patents detail methods for enhancing existing levels of receptor activity and include compositions for the effective use of these chemical entities.
Career Highlights
Throughout his career, Steven Sethofer has worked with several companies, including Carmot Therapeutics, Inc. and Cannot Therapeutics, Inc. His expertise in receptor modulation has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Sethofer has collaborated with notable professionals in his field, including Raymond V. Fucini and Stig Hansen. These collaborations have further enriched his research and development efforts.
Conclusion
Steven Sethofer's innovative work in the modulation of G-protein coupled receptors showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatment options for various health conditions.